v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Varex Equity
Total Varex Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Common stock, shares, outstanding, beginning balance (in shares) at Oct. 01, 2021         39,400,000            
Stockholders' equity, outstanding, beginning balance at Oct. 01, 2021 $ 496.5   $ 483.3   $ 0.4 $ 449.4   $ 0.0 $ 33.5   $ 13.2
Increase (Decrease) in Stockholders' Equity                      
Net income 1.6   1.4           1.4   0.2
Exercise of stock options (in shares)         100,000            
Exercise of stock options 3.5   3.5     3.5          
Common stock issued under employee stock purchase plan (in shares)         100,000            
Common stock issued under employee stock purchase plan 1.7   1.7     1.7          
Share-based compensation 3.4   3.4     3.4          
Foreign currency translation adjustments (0.5)   (0.5)         (0.5)      
Other (0.1)                   (0.1)
Common stock, shares, outstanding, ending balance (in shares) at Dec. 31, 2021         39,600,000            
Stockholders' equity, outstanding, ending balance at Dec. 31, 2021 506.1   492.8   $ 0.4 458.0   (0.5) 34.9   13.3
Common stock, shares, outstanding, beginning balance (in shares) at Oct. 01, 2021         39,400,000            
Stockholders' equity, outstanding, beginning balance at Oct. 01, 2021 $ 496.5   483.3   $ 0.4 449.4   0.0 33.5   13.2
Common stock, shares, outstanding, ending balance (in shares) at Sep. 30, 2022 40,085,126       40,100,000            
Stockholders' equity, outstanding, ending balance at Sep. 30, 2022 $ 546.7 $ (28.1) 533.4 $ (28.1) $ 0.4 469.1 $ (34.6) 0.1 63.8 $ 6.5 13.3
Increase (Decrease) in Stockholders' Equity                      
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06                    
Net income $ 3.2   3.1           3.1   0.1
Share-based compensation 3.3   3.3     3.3          
Other $ (0.1)         0.1     (0.1)   (0.1)
Common stock, shares, outstanding, ending balance (in shares) at Dec. 30, 2022 40,087,100       40,100,000            
Stockholders' equity, outstanding, ending balance at Dec. 30, 2022 $ 525.0   $ 511.7   $ 0.4 $ 437.9   $ 0.1 $ 73.3   $ 13.3